MARINE PETROLEUM TRUST (MARPS)

US5684231070

3.79  +0.01 (+0.26%)

After market: 3.8 +0.01 (+0.26%)

Fundamental Rating

5

Overall MARPS gets a fundamental rating of 5 out of 10. We evaluated MARPS against 205 industry peers in the Oil, Gas & Consumable Fuels industry. While MARPS has a great profitability rating, there are some minor concerns on its financial health. MARPS has a valuation in line with the averages, but on the other hand it scores bad on growth.



8

1. Profitability

1.1 Basic Checks

MARPS had positive earnings in the past year.
MARPS had a positive operating cash flow in the past year.
Each year in the past 5 years MARPS has been profitable.
In the past 5 years MARPS always reported a positive cash flow from operatings.

1.2 Ratios

With an excellent Return On Assets value of 71.22%, MARPS belongs to the best of the industry, outperforming 96.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of 71.22%, MARPS belongs to the top of the industry, outperforming 95.10% of the companies in the same industry.
The Return On Invested Capital of MARPS (56.27%) is better than 98.04% of its industry peers.
MARPS had an Average Return On Invested Capital over the past 3 years of 84.02%. This is significantly above the industry average of 29.02%.
The last Return On Invested Capital (56.27%) for MARPS is well below the 3 year average (84.02%), which needs to be investigated, but indicates that MARPS had better years and this may not be a problem.
Industry RankSector Rank
ROA 71.22%
ROE 71.22%
ROIC 56.27%
ROA(3y)106.35%
ROA(5y)79.49%
ROE(3y)106.35%
ROE(5y)79.49%
ROIC(3y)84.02%
ROIC(5y)62.8%

1.3 Margins

With an excellent Profit Margin value of 68.94%, MARPS belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
MARPS's Profit Margin has been stable in the last couple of years.
The Operating Margin of MARPS (68.93%) is better than 93.63% of its industry peers.
In the last couple of years the Operating Margin of MARPS has remained more or less at the same level.
Industry RankSector Rank
OM 68.93%
PM (TTM) 68.94%
GM N/A
OM growth 3Y18.49%
OM growth 5Y-1.41%
PM growth 3Y18.49%
PM growth 5Y-1.41%
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, MARPS has about the same amount of shares outstanding.
Compared to 5 years ago, MARPS has about the same amount of shares outstanding.
MARPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MARPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

1

3. Growth

3.1 Past

The earnings per share for MARPS have decreased strongly by -33.46% in the last year.
The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
Looking at the last year, MARPS shows a very negative growth in Revenue. The Revenue has decreased by -22.78% in the last year.
MARPS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.97% yearly.
EPS 1Y (TTM)-33.46%
EPS 3Y64.57%
EPS 5Y2.19%
EPS Q2Q%6.16%
Revenue 1Y (TTM)-22.78%
Revenue growth 3Y38.89%
Revenue growth 5Y3.97%
Sales Q2Q%0.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

MARPS is valuated reasonably with a Price/Earnings ratio of 10.53.
MARPS's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.73, MARPS is valued rather cheaply.
Industry RankSector Rank
PE 10.53
Fwd PE N/A

4.2 Price Multiples

63.73% of the companies in the same industry are more expensive than MARPS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.58
EV/EBITDA N/A

4.3 Compensation for Growth

The excellent profitability rating of MARPS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.81
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.40%, MARPS is a good candidate for dividend investing.
MARPS's Dividend Yield is rather good when compared to the industry average which is at 6.85. MARPS pays more dividend than 84.31% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.24, MARPS pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.4%

5.2 History

The dividend of MARPS has a limited annual growth rate of 2.24%.
MARPS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.24%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MARPS pays out 94.05% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MARPS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP94.05%
EPS Next 2YN/A
EPS Next 3YN/A

MARINE PETROLEUM TRUST

NASDAQ:MARPS (12/20/2024, 8:23:28 PM)

After market: 3.8 +0.01 (+0.26%)

3.79

+0.01 (+0.26%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)02-12 2025-02-12
Inst Owners1.94%
Inst Owner Change-5.04%
Ins Owners19.42%
Ins Owner ChangeN/A
Market Cap7.58M
Analysts0
Price TargetN/A
Short Float %0.2%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 9.4%
Dividend Growth(5Y)2.24%
DP94.05%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-29 2024-11-29 (0.102923)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.53
Fwd PE N/A
P/S 7.27
P/FCF 10.58
P/OCF 10.58
P/B 7.51
P/tB 7.51
EV/EBITDA N/A
EPS(TTM)0.36
EY9.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.36
FCFY9.46%
OCF(TTM)0.36
OCFY9.46%
SpS0.52
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)4.81
Profitability
Industry RankSector Rank
ROA 71.22%
ROE 71.22%
ROCE 71.22%
ROIC 56.27%
ROICexc 5677340%
ROICexgc 5677340%
OM 68.93%
PM (TTM) 68.94%
GM N/A
FCFM 68.75%
ROA(3y)106.35%
ROA(5y)79.49%
ROE(3y)106.35%
ROE(5y)79.49%
ROIC(3y)84.02%
ROIC(5y)62.8%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)106.35%
ROCE(5y)79.49%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y18.49%
OM growth 5Y-1.41%
PM growth 3Y18.49%
PM growth 5Y-1.41%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 99.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)100%
Profit Quality(5y)100%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.46%
EPS 3Y64.57%
EPS 5Y2.19%
EPS Q2Q%6.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.78%
Revenue growth 3Y38.89%
Revenue growth 5Y3.97%
Sales Q2Q%0.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.07%
EBIT growth 3Y64.57%
EBIT growth 5Y2.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.85%
FCF growth 3Y64.57%
FCF growth 5Y2.51%
OCF growth 1Y-52.85%
OCF growth 3Y64.57%
OCF growth 5Y2.51%